Authors
Loading...
Clinical trial demonstrates that combining acylated and unacylated ghrelin improves insulin sensitivity in growth hormone-deficient adults, suggesting therapeutic utility for metabolic disorders.
Gauna et al. (2004) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: